Australia's medical research body advises conditional puberty blockers for trans children, clashing with Queensland and NT bans

Advocates say state bans have caused significant harm, including young people missing puberty blockers by weeks and suffering lasting effects such as voice breaks.
Missed puberty blockers by a couple of weeks because of the ban
Betce Benjamin described harm to young Queenslanders under the state's public hospital ban.
Mark

Why does this guidance matter if neither state is changing course?

Mimi

Because it's the country's leading medical research authority, commissioned by the federal government specifically in response to these bans. It gives the dispute an official clinical reference point.

Mark

What does it actually recommend?

Mimi

Puberty suppressants in certain circumstances, with care decided case by case. It doesn't require a child to be distressed, and it rejects "wait and see" as a form of withholding care.

Luke

Worth noting it's interim. Consultation runs to 18 January, and the full guidelines aren't due until 2028, so the wording could change.

Mark

And Queensland's response?

Mimi

Nicholls says an independent review already settled it. The ban stands, and it's been extended to 2031.

Luke

Aiken calls the guidance the "reverse Cass" and says it makes the ban clinically inappropriate. That's a clinician's view, not a finding of the council.

Mark

What about the harm claims?

Mimi

Betce Benjamin described young people missing blockers by weeks and losing their voices after breaking. It's a powerful account.

Luke

But it's one person's account of cases they know of. Benjamin themself said the true cost won't be known for years, and the article offers no data on it.

Mark

So what's next?

Mimi

Consultation, then the hormone guidance, with Butler hoping states will weigh it though he can't compel them.

  • A national medical body has directly contradicted state hospital bans, sharpening a clash between Canberra and Brisbane and Darwin.
  • Queensland's minister points to an independent review and says his position is unchanged, while the Northern Territory says its ban will stand.
  • Advocates describe young people who missed puberty blockers by only weeks and may carry lasting effects such as broken voices.
  • Public consultation on the interim advice runs until 18 January, with full guidelines covering hormones expected in 2028, and the states show no sign of yielding yet.

In a season when a nation's healthcare is being pulled between its states and its best medical counsel, Australia's National Health and Medical Research Council has offered interim guidance that puberty suppressants can be a sound choice for some gender-incongruent children, and that waiting may itself cause harm. The advice speaks to a long human question: how to care for young people whose bodies and sense of self are still taking shape, while adults argue over the proper limits of medicine. It arrives at a moment when Queensland and the Northern Territory have held firm to bans on these treatments in public hospitals, leaving families and clinicians to weigh a national view against state decisions. Whether the guidance will ultimately shift those choices remains an open question, to be answered through public consultation and the fuller guidelines still to come.

On Monday, Australia's National Health and Medical Research Council released interim national guidelines advising that puberty suppressants can be used for some gender-incongruent children in certain circumstances. The advice lands squarely against public hospital bans in Queensland and the Northern Territory. The federal government had commissioned the council last year in response to those bans, and federal health minister Mark Butler said the commonwealth cannot intervene, expressing confidence that state governments would weigh the advice closely.

Neither state has moved. Queensland's health minister, Tim Nicholls, said the state had completed an independent review and that its position was unchanged. The Northern Territory said its ban would continue. Queensland's ban, introduced in 2025, was once ruled unlawful by the state supreme court, after it emerged the minister had not consulted health authorities; he reinstated it immediately and later extended it to 2031.

The guidelines describe gender incongruence as a difference between gender and sex recorded at birth, not a mental health disorder, and do not require a child to be distressed before receiving care. They reject a "wait and see" approach as a form of withholding care that can harm a young person's health and ability to function. For advocates, the guidance is a vindication. Dr Stuart Aiken of Gender Health Australia, a Brisbane clinic founded in response to the ban, called it a reverse of the UK Cass review.

For trans Queenslanders, the moment brings relief mixed with grief. Betce Benjamin said many in the community felt validated, and that the bans had already cost young people dearly, including some whose voices broke after missing blockers by only a couple of weeks. The public consultation remains open until 18 January, and the wider guidelines will follow in 2028.

On Monday, Australia's National Health and Medical Research Council released interim national clinical practice guidelines that advise using puberty suppressants for gender incongruence in children in certain circumstances. The advice lands directly against the public hospital bans imposed by the Queensland and Northern Territory governments.

The federal government commissioned the council, which is funded by the commonwealth, to develop the advice last year. That was in response to the two bans. Federal health minister Mark Butler said the bans are a matter for the states and the commonwealth cannot intervene. He said he expected both governments to weigh the guidelines. "I am very confident that every state government, no matter their political persuasion, will consider the advice of our pre-eminent authority very closely," he said.

Neither government signalled movement. Queensland health minister Tim Nicholls said the state had already undertaken an independent review and made a clear decision on these treatments in its public hospitals. "Our position remains unchanged and we will continue to prioritise the health, safety and wellbeing of young Queenslanders," he said. The Northern Territory government said in a statement that its ban would continue despite the advice.

The guidelines describe gender incongruence as the clinical term for a difference between a person's gender and the sex recorded at birth, and state that it is not a mental health disorder. Some young people with it also experience significant distress, known as gender dysphoria, but the guidelines do not require a child to be distressed in order to be treated. They say the makeup of a multi-disciplinary team should be settled case by case, and that doctors should prioritise the young person's best interest and wellbeing and provide care that respects their autonomy.

The council explicitly rejected alternatives put forward by opponents, including a "wait and see" model, describing them as a form of withholding care that can affect a young person's physical and mental health, wellbeing and ability to function. It also said trans and gender-diverse young people face unjust and avoidable health disparities arising from stigma, discrimination and barriers to care. Puberty blockers are drugs that stop the body producing oestrogen and testosterone. They are covered by the Pharmaceutical Benefits Scheme for cisgender patients and have been used for decades.

Queensland's ban, introduced in 2025, stops the state's public hospitals from prescribing puberty blockers or hormone therapy to new patients. Nicholls leaned on the UK review led by paediatrician Hilary Cass, which did not consider Australian health standards, to justify it. The Queensland supreme court later ruled the ban unlawful in 2025, after Guardian reporting showed Nicholls had not consulted health authorities before making it. He reinstated the ban immediately and later extended it until 2031.

Dr Stuart Aiken, medical director of Gender Health Australia, a Brisbane clinic founded in direct response to the ban, said the advice "makes an absolute joke of the Queensland government's decision" and that the decision has caused huge amounts of harm. He called the guidelines the "reverse Cass" and an antidote to it, because they refocus on gender identity as another variation in human experience. He said they make Queensland's decision seem clinically inappropriate.

Transgender Queenslander Betce Benjamin said the community felt validated and many were already celebrating, noting how many people had contacted them with joy. Benjamin said the bans had harmed young people, though the full cost would not be known for years. They said they knew of young people whose voices broke, leaving them mute, because they missed out on puberty blockers by a couple of weeks as a result of the ban.

Public consultation on the interim advice, titled "Advice on the use of puberty suppressants in the care of trans and gender-diverse people aged under 18", is open until 18 January. The full guidelines will cover other aspects of care, including gender-affirming hormones, and are expected in 2028.

Our position remains unchanged and we will continue to prioritise the health, safety and wellbeing of young Queenslanders.
— Tim Nicholls, Queensland health minister
I am very confident that every state government, no matter their political persuasion, will consider the advice of our pre-eminent authority very closely.
— Mark Butler, federal health minister
Quer a matéria completa? Leia o original em The Guardian ↗
Fale Conosco FAQ